Oracle Corporation $ORCL Shares Bought by TriaGen Wealth Management LLC

TriaGen Wealth Management LLC lifted its stake in Oracle Corporation (NYSE:ORCL) by 2.9% in the 2nd quarter, Holdings Channel.com reports. The firm owned 3,696 shares of the enterprise software provider’s stock after purchasing an additional 104 shares during the period. TriaGen Wealth Management LLC’s holdings in Oracle were worth $808,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Harel Insurance Investments & Financial Services Ltd. increased its position in shares of Oracle by 71.6% during the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 257,378 shares of the enterprise software provider’s stock worth $35,984,000 after acquiring an additional 107,404 shares during the period. Lockheed Martin Investment Management Co. increased its stake in Oracle by 4.3% in the first quarter. Lockheed Martin Investment Management Co. now owns 51,350 shares of the enterprise software provider’s stock valued at $7,179,000 after purchasing an additional 2,110 shares during the last quarter. Lockerman Financial Group Inc. acquired a new stake in Oracle during the second quarter worth approximately $328,000. Elser Financial Planning Inc purchased a new stake in shares of Oracle during the 2nd quarter worth approximately $1,066,000. Finally, Canoe Financial LP boosted its holdings in shares of Oracle by 314.8% in the 2nd quarter. Canoe Financial LP now owns 484,098 shares of the enterprise software provider’s stock valued at $105,838,000 after buying an additional 367,400 shares in the last quarter. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ORCL has been the subject of several research reports. Wolfe Research boosted their target price on Oracle from $300.00 to $400.00 and gave the company an “outperform” rating in a report on Wednesday, September 10th. UBS Group set a $364.00 price objective on Oracle in a research report on Friday, September 26th. Stifel Nicolaus lifted their target price on Oracle from $250.00 to $350.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. William Blair restated an “outperform” rating on shares of Oracle in a research note on Monday, September 22nd. Finally, Piper Sandler lifted their price objective on shares of Oracle from $270.00 to $330.00 and gave the company an “overweight” rating in a research report on Wednesday, September 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $304.71.

Insider Transactions at Oracle

In related news, Director Naomi O. Seligman sold 2,222 shares of the business’s stock in a transaction dated Friday, September 26th. The shares were sold at an average price of $288.91, for a total value of $641,958.02. Following the sale, the director directly owned 29,225 shares in the company, valued at $8,443,394.75. The trade was a 7.07% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Michael D. Sicilia sold 33,845 shares of the firm’s stock in a transaction dated Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the transaction, the insider owned 132,656 shares of the company’s stock, valued at $42,603,800.96. This trade represents a 20.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 104,314 shares of company stock worth $31,272,223 over the last ninety days. 40.90% of the stock is currently owned by company insiders.

Oracle Stock Up 2.0%

Shares of NYSE ORCL opened at $291.77 on Tuesday. The stock has a market capitalization of $831.77 billion, a price-to-earnings ratio of 67.54, a price-to-earnings-growth ratio of 3.08 and a beta of 1.53. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $345.72. The firm has a 50-day moving average price of $263.41 and a 200 day moving average price of $206.82. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle (NYSE:ORCL) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The company had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. During the same quarter in the previous year, the company posted $1.39 earnings per share. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities research analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 0.7%. Oracle’s payout ratio is currently 46.30%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.